Clinical Trial Update: Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions [NA]

View source ↗

Summary

A completed clinical trial evaluated the effectiveness of Intercoat (Oxiplex/AP Gel) in reducing intrauterine adhesions in Asherman syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asherman Syndrome

Drugs mentioned

• Intercoat (Oxiplex/AP Gel) (Oxiplex/AP Gel)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Asherman Syndrome | NA | Status: COMPLETED